FIELD: medicine.
SUBSTANCE: invention relates to medicine and chemical-pharmaceutical industry, namely to improved gramicidin C substances containing certain amounts of new cyclic decapeptides from the gramicidin C family, as well as to pharmaceutical compositions containing them for the treatment of infectious and inflammatory diseases.
EFFECT: obtaining pharmaceutical compositions for treatment of infectious-inflammatory diseases.
27 cl, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEPTAPEPTIDE AMIDES FOR THE TREATMENT OF HMGB1-DEPENDENT DISEASES | 2021 |
|
RU2760133C1 |
| HEMIN DERIVATIVES, HAVING ANTIMICROBIAL ACTIVITY OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, SYNTHESIS METHOD, PHARMACEUTICAL COMPOSITION AND USE | 2009 |
|
RU2415868C1 |
| ANTIBACTERIAL COMPOSITION OF GRAMICIDIN C, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2800287C1 |
| CYCLODECAPEPTIDE ANTIBIOTIC LATEROCIDIN WITH BROAD SPECTRUM OF ANTAGONISTIC EFFECT, STRAIN OF BACTERIUM BREVIBACILLUS LATEROSPORUS ELICITING BROAD SPECTRUM OF ANTAGONISTIC EFFECT AS PRODUCER OF ANTIBIOTIC LATEROCIDIN | 2002 |
|
RU2229520C1 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| SYNTHETIC PEPTIDE AMIDES AND THEIR DIMERS | 2007 |
|
RU2510399C2 |
| ANTIRETROVIRAL DRUG AIMED AT HUMAN ENDOGENOUS RETROVIRUS | 2015 |
|
RU2689326C1 |
| COMPOSITIONS AND METHODS RELATING TO DRUG CONJUGATES WITH ANTI-CD19 ANTIBODIES | 2019 |
|
RU2806333C2 |
| CYCLOPEPTIDES, A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR AND A METHOD OF THEIR PREPARING | 1994 |
|
RU2130030C1 |
| KAHALALIDE F DERIVATIVES | 2004 |
|
RU2395520C2 |
